Skip to main content
Equibles
AZN logo

AZN · Astrazeneca PLC

Track AZN — free

Use AZN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AZN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$156.45 -0.79 (-0.50%) At close · Aug 14
Market Cap
$242.64B
Shares
1.55B

Astrazeneca PLC Earnings Call Transcripts

Every quarterly earnings call for Astrazeneca PLC (AZN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q1
2026-04-29
Astrazeneca PLC Q1 FY2026 Earnings Call
Confident tone Q1 financial performance Upcoming launches Pipeline and R&D
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
Astrazeneca PLC Q4 FY2025 Earnings Call
Confident tone Pipeline and Phase III catalysts Revenue and financial growth Geographic diversification
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Astrazeneca PLC Q3 FY2025 Earnings Call
Confident tone Rare Disease and Biopharmaceuticals Financial performance and guidance Pipeline and Phase III readouts
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Astrazeneca PLC Q2 FY2025 Earnings Call
Confident tone Oncology portfolio expansion Rare disease and C5 franchise China VBP and Farxiga
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Astrazeneca PLC Q1 FY2025 Earnings Call
Confident tone Oncology Performance (Tagrisso, Calquence, Imfinzi) Tariffs and Manufacturing Footprint China and Emerging Markets
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Astrazeneca PLC Q4 FY2024 Earnings Call
Confident tone 2024 financial performance Gross margin guidance China business and investigations
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Astrazeneca PLC Q3 FY2024 Earnings Call
Confident tone Broad-based revenue growth across regions U.S. manufacturing and R&D investment China investigations and business impact
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Astrazeneca PLC Q2 FY2024 Earnings Call
Confident tone Revenue and Earnings Growth China and Emerging Markets Inflation Reduction Act / IRA
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Astrazeneca PLC Q1 FY2024 Earnings Call
Confident tone Biopharmaceuticals and respiratory Organizational structure Capital allocation and M&A
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Astrazeneca PLC Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–10 of 10 earnings calls
Key facts CIK 901832 CUSIP G0593M107 13F (30d) 1248 filings 1218 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)